» Articles » PMID: 35320401

The Effect of a Natural Polyphenol Supplement on Iron Absorption in Adults with Hereditary Hemochromatosis

Abstract

Objectives: We developed a natural polyphenol supplement that strongly chelates iron in vitro and assessed its effect on non-heme iron absorption in patients with hereditary hemochromatosis (HH).

Methods: We performed in vitro iron digestion experiments to determine iron precipitation by 12 polyphenol-rich dietary sources, and formulated a polyphenol supplement (PPS) containing black tea powder, cocoa powder and grape juice extract. In a multi-center, single-blind, placebo-controlled cross-over study, we assessed the effect of the PPS on iron absorption from an extrinsically labelled test meal and test drink in patients (n = 14) with HH homozygous for the p.C282Y variant in the HFE gene. We measured fractional iron absorption (FIA) as stable iron isotope incorporation into erythrocytes.

Results: Black tea powder, cocoa powder and grape juice extract most effectively precipitated iron in vitro. A PPS mixture of these three extracts precipitated ~ 80% of iron when 2 g was added to a 500 g iron solution containing 20 µg Fe/g. In the iron absorption study, the PPS reduced FIA by ~ 40%: FIA from the meal consumed with the PPS was lower (3.01% (1.60, 5.64)) than with placebo (5.21% (3.92, 6.92)) (p = 0.026)), and FIA from the test drink with the PPS was lower (10.3% (7.29 14.6)) than with placebo (16.9% (12.8 22.2)) (p = 0.002).

Conclusion: Our results indicate that when taken with meals, this natural PPS can decrease dietary iron absorption, and might thereby reduce body iron accumulation and the frequency of phlebotomy in patients with HH.

Trial Registry: clinicaltrials.gov (registration date: 9.6.2019, NCT03990181).

Citing Articles

Differences in nonheme iron absorption between healthy adults of East Asian or Northern European ancestry from the Iron Genes in East Asian and Northern European Adults Study (FeGenes): A cross-sectional stable iron isotope study.

Barad A, Xu Y, Bender E, Pressman E, Gu Z, OBrien K Am J Clin Nutr. 2025; 121(2):417-426.

PMID: 39909711 PMC: 11863334. DOI: 10.1016/j.ajcnut.2024.11.015.


Versatility of Caenorhabditis elegans as a Model Organism for Evaluating Foodborne Neurotoxins and Food Bioactive Compounds in Nutritional Neuroscience.

Adedara I, Weis G, Monteiro C, Soares F, Rocha J, Schetinger M Mol Neurobiol. 2025; .

PMID: 39863742 DOI: 10.1007/s12035-025-04705-y.


Production of iron enriched Saccharomyces boulardii: impact of process variables.

Tafazzoli K, Ghavami M, Khosravi-Darani K Sci Rep. 2024; 14(1):4844.

PMID: 38418660 PMC: 10902395. DOI: 10.1038/s41598-024-55433-7.


Phytochemicals and Vitamin D for a Healthy Life and Prevention of Diseases.

Santa K, Watanabe K, Kumazawa Y, Nagaoka I Int J Mol Sci. 2023; 24(15).

PMID: 37569540 PMC: 10419318. DOI: 10.3390/ijms241512167.

References
2.
Bacon B, Adams P, Kowdley K, Powell L, Tavill A . Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011; 54(1):328-43. PMC: 3149125. DOI: 10.1002/hep.24330. View

3.
Adams P, Reboussin D, Barton J, McLaren C, Eckfeldt J, McLaren G . Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005; 352(17):1769-78. DOI: 10.1056/NEJMoa041534. View

4.
Phatak P, Bonkovsky H, Kowdley K . Hereditary hemochromatosis: time for targeted screening. Ann Intern Med. 2008; 149(4):270-2. DOI: 10.7326/0003-4819-149-4-200808190-00009. View

5.
Crownover B, Covey C . Hereditary hemochromatosis. Am Fam Physician. 2013; 87(3):183-90. View

6.
Bardou-Jacquet E, Brissot P . Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). Hematol Oncol Clin North Am. 2014; 28(4):625-35, v. DOI: 10.1016/j.hoc.2014.04.006. View